Scientific symposium on vaccination against influenza: Kemi, Finland, 22 March 2002ZAMBON, Maria; WOOD, John M.Vaccine. Supplement. 2002, Vol 20, issn 1359-5938, 56 p., 5Conference Proceedings

Molecular diagnosis of influenzaELLIS, Joanna S; ZAMBON, Maria C.Reviews in medical virology. 2002, Vol 12, Num 6, pp 375-389, issn 1052-9276, 15 p.Article

InfluenzaNICHOLSON, Karl G; WOOD, John M; ZAMBON, Maria et al.Lancet (British edition). 2003, Vol 362, Num 9397, pp 1733-1745, issn 0140-6736, 13 p.Article

Combined PCR-heteroduplex mobility assay for detection and differentiation of influenza A viruses from different animal speciesELLIS, Joanna S; ZAMBON, Maria C.Journal of clinical microbiology (Print). 2001, Vol 39, Num 11, pp 4097-4102, issn 0095-1137Article

Position statement : global neuraminidase inhibitor susceptibility networkZAMBON, Maria; HAYDEN, Frederick G.Antiviral research. 2001, Vol 49, Num 3, pp 147-156, issn 0166-3542Article

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispeciesLACKENBY, Angie; DEMOCRATIS, Jane; SIQUEIRA, Marilda M et al.Antiviral therapy (London). 2008, Vol 13, Num 6, pp 809-820, issn 1359-6535, 12 p.Article

Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human hostTHOMPSON, Catherine I; BARCLAY, Wendy S; ZAMBON, Maria C et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 759-765, issn 0305-7453, 7 p.Article

Diagnosis of influenza in the community : Relationship of Clinical diagnosis to confirmed virological, serologic, or molecular detection of influenzaZAMBON, Maria; HAYS, John; WEBSTER, Alison et al.Archives of internal medicine (1960). 2001, Vol 161, Num 17, pp 2116-2122, issn 0003-9926Article

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological studyMILLER, Elizabeth; HOSCHLER, Katja; HARDELID, Pia et al.Lancet (British edition). 2010, Vol 375, Num 9720, pp 1100-1108, issn 0140-6736, 9 p.Article

Nucleic Acid Dipstick Test for Molecular Diagnosis of Pandemic H1N1WU, Liang-Ta; CURRAN, Martin D; ELLIS, Joanna S et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 10, pp 3608-3613, issn 0095-1137, 6 p.Article

Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine : Impact of distinct additional adjuvantsRADOSEVIC, Katarina; RODRIGUEZ, Ariane; MINTARDJO, Ratna et al.Vaccine. 2008, Vol 26, Num 29-30, pp 3640-3646, issn 0264-410X, 7 p.Article

Re-emergence of fatal human influenza A subtype H5N1 disease. CommentaryPEIRIS, J. S. M; YU, W. C; YUEN, K. Y et al.Lancet (British edition). 2004, Vol 363, Num 9409, pp 582-583, issn 0140-6736, 5 p.Article

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccinationPEDERSEN, Gabriel Kristian; HÖSCHLER, Katja; SJURSEN, Haakon et al.Vaccine. 2014, Vol 32, Num 35, pp 4550-4557, issn 0264-410X, 8 p.Article

Risk and protective factors for meningococcal disease in adolescents : matched cohort studyTULLY, Joanna; VINER, Russell M; COEN, Pietro G et al.BMJ. British medical journal (International ed.). 2006, Vol 332, Num 7539, pp 445-448, issn 0959-8146, 4 p.Article

Near patient testing for influenza in children in primary care: comparison with laboratory testHARNDEN, Anthony; BRUEGGEMANN, Angela; SHEPPERD, Sasha et al.BMJ. British medical journal (International ed.). 2003, Vol 326, Num 7387, issn 0959-8146, p. 480Article

Current research on respiratory viral infections: Fourth International SymposiumISON, Michael G; MILLS, John; OPENSHAW, Peter et al.Antiviral research. 2002, Vol 55, Num 2, pp 227-278, issn 0166-3542Article

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trialJONES, Suzanne; EVANS, Kirsten; BEADLE, John et al.Vaccine. 2009, Vol 27, Num 18, pp 2506-2512, issn 0264-410X, 7 p.Article

Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children. CommentarySTEPHENSON, Lain; DEMOCRATIS, Jane; MONTO, Arnold S et al.Clinical infectious diseases. 2009, Vol 48, Num 4, pp 389-399, issn 1058-4838, 11 p.Article

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines-Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum-Given Concomitantly with Influenza Vaccine to High-Risk Elderly IndividualsFALSEY, Ann R; WALSH, Edward E; NEUZIL, Kathleen M et al.The Journal of infectious diseases. 2008, Vol 198, Num 9, pp 1317-1326, issn 0022-1899, 10 p.Article

First external quality assurance of antibody diagnostic for SARS-new coronavirusNIEDRIG, Matthias; LEITMEYER, Katrin; LIM, Wilina et al.Journal of clinical virology. 2005, Vol 34, Num 1, pp 22-25, issn 1386-6532, 4 p.Article

Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike proteinYONG XIU YAO; JUNYUAN REN; HEINEN, Paul et al.The Journal of infectious diseases. 2004, Vol 190, Num 1, pp 91-98, issn 0022-1899, 8 p.Article

Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human hostHARVEY, Ruth; MARTIN, Andrew C. R; ZAMBON, Maria et al.Journal of virology. 2004, Vol 78, Num 1, pp 502-507, issn 0022-538X, 6 p.Article

Antiviral resistance during the 2009 influenza A H1Nl pandemic: public health, laboratory, and clinical perspectivesHURT, Aeron C; CHOTPITAYASUNONDH, Tawee; LIM, Wilina et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 3, pp 240-248, issn 1473-3099, 9 p.Article

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M^™ adjuvant in a phase I clinical trialCOX, Rebecca J; PEDERSEN, Gabriel; WEVERLING, Gerritjan et al.Vaccine. 2011, Vol 29, Num 45, pp 8049-8059, issn 0264-410X, 11 p.Article

Page / 3